"Clindamycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
Descriptor ID |
D002981
|
MeSH Number(s) |
D03.383.773.532.500.125 D09.408.471.500.125
|
Concept/Terms |
Clindamycin- Clindamycin
- Chlolincocin
- 7-Chloro-7-deoxylincomycin
- 7 Chloro 7 deoxylincomycin
- Chlorlincocin
|
Below are MeSH descriptors whose meaning is more general than "Clindamycin".
Below are MeSH descriptors whose meaning is more specific than "Clindamycin".
This graph shows the total number of publications written about "Clindamycin" by people in this website by year, and whether "Clindamycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2006 | 1 | 1 | 2 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2010 | 2 | 0 | 2 |
2016 | 1 | 1 | 2 |
2017 | 2 | 5 | 7 |
2018 | 6 | 7 | 13 |
2019 | 4 | 1 | 5 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Clindamycin" by people in Profiles.
-
Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19. Emerg Infect Dis. 2020 Aug; 26(8):1939-1941.
-
High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis. Int J Antimicrob Agents. 2019 Aug; 54(2):143-148.
-
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study J Drugs Dermatol. 2019 May 01; 18(5):437-438.
-
Fulminant arterial vasculitis as an unusual complication of disseminated staphylococcal disease due to the emerging CC1 methicillin-susceptible Staphylococcus aureus clone: a case report. BMC Infect Dis. 2019 Apr 03; 19(1):302.
-
Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes. J Am Acad Dermatol. 2019 May; 80(5):1455-1457.
-
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance. Br J Dermatol. 2019 04; 180(4):949.
-
Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations. J Am Acad Dermatol. 2019 May; 80(5):1314-1321.
-
Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis. Clin Infect Dis. 2018 10 15; 67(9):1434-1436.
-
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection. Antimicrob Agents Chemother. 2018 10; 62(10).
-
An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience. G Ital Dermatol Venereol. 2020 Dec; 155(6):749-753.